VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance

Mohamed A. ElTanbouly
Harvard Medical School
January 1, 2020
Science
https://pubmed.ncbi.nlm.nih.gov/31949051

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/31949051

Research summary

This study identifies VISTA as a distinct negative checkpoint regulator on naïve T cells, crucial for maintaining immune quiescence and self-tolerance. Using both VISTA Knockout and humanized VISTA Knockin mouse models, the authors demonstrated that loss of VISTA disrupts naïve T cell homeostasis and enhances self-reactivity. Agonistic targeting of VISTA promoted peripheral deletion of autoreactive T cells and immune tolerance.

Key outcome of the study

VISTA promotes naïve T cell quiescence and peripheral tolerance. Humanized VISTA models confirm conserved function and relevance to therapeutic checkpoint modulation.

Mouse model

Humanized VISTA Knockin mouse model developed by genOway (alongside VISTA Knockout), expressing human VSIR to evaluate tolerance and quiescence in vivo.

TARGET:
VSIR
VISTA, PD-1H, C10orf54

Keywords

T cell tolerance, Autoimmunity, Immune checkpoints, Naïve T cells, VISTA targeting

Technical specifications

Humanized Knockin model, VISTA gene replacement, Vsir Knockout

Related products

Catalogue product

genO‑hVISTA

The genO‑hVISTA mouse enables the in vivo efficacy assessment and profiling of immuno-oncology agents targeting the human immune checkpoint VISTA in fully immunocompetent mice.

Customized product

No items found.